Table 4.
Prevalence of antimicrobial resistance (AMR) phenotypes of EAEC isolated from diarrheal and non-diarrheal cases among Bolivian children. ns = nonsignificant.
| Drug Class | Antibiotics | Diarrheal Isolates (D) | Non-Diarrheal Isolates (ND) |
p-Value (D vs. ND) |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| t-EAEC (172) |
a-EAEC (239) |
Total (n = 411) |
p-Value (D) |
t-EAEC (30) | a-EAEC (27) | Total (n = 57) |
p-Value (ND) |
|||||||||
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |||||
| Penicillins | AM | 158 | (91.9) | 226 | (94.6) | 384 | (93.4) | ns | 28 | (93.3) | 21 | (77.8) | 49 | (86.0) | ns | ns |
| SAM | 88 | (51.2) | 128 | (53.6) | 216 | (52.6) | ns | 18 | (60.0) | 13 | (48.1) | 31 | (54.4) | ns | ns | |
| Cephalosporins | FOX | 24 | (14.0) | 20 | (8.4) | 44 | (10.7) | ns | 6 | (20.0) | 6 | (22.2) | 12 | (21.1) | ns | 0.0468 |
| CTX | 12 | (7.0) | 6 | (2.5) | 18 | (4.4) | 0.0447 | 3 | (10.0) | 4 | (14.8) | 7 | (12.3) | ns | 0.0023 | |
| Chloramphenicol | CHL | 38 | (22.1) | 54 | (22.6) | 92 | (22.4) | ns | 5 | (16.7) | 5 | (18.5) | 10 | (17.5) | ns | ns |
| Fluoroquinolones | CIP | 1 | (0.6) | 4 | (1.7) | 5 | (1.2) | ns | 2 | (6.7) | 1 | (3.7) | 3 | (5.3) | ns | ns |
| NAL | 30 | (17.4) | 49 | (20.5) | 79 | (19.2) | ns | 9 | (30.0) | 6 | (22.2) | 15 | (26.3) | ns | ns | |
| Tetracyclines | TET | 100 | (58.1) | 115 | (48.1) | 215 | (52.3) | ns | 19 | (63.3) | 12 | (44.4) | 31 | (54.4) | ns | ns |
| Sulphonamides | SXT | 117 | (68.0) | 189 | (79.1) | 306 | (74.5) | ns | 21 | (70.0) | 10 | (37.0) | 31 | (54.4) | ns | 0.0024 |
| MDR | 96 | (55.8) | 153 | (64.0) | 249 | (60.6) | ns | 19 | (63.3) | 11 | (40.7) | 30 | (52.6) | ns | ns | |